Dario Amodei: 10x Growth and Why 'Doomer' Makes Him Angry

Why This Is Amodei’s Most Revealing Interview

This is Dario Amodei at his most unfiltered. The Anthropic CEO sits down with Alex Kantrowitz for the Big Technology Podcast and delivers what might be the most revealing interview any frontier AI lab leader has given in 2025.

The business numbers are staggering: Anthropic went from zero to $100M in 2023, $100M to $1B in 2024, and $1B to $4.5B in the first half of 2025. “Every year I suspect we’ll grow at that scale and every year I’m almost afraid to say it publicly because I’m like, no, it couldn’t possibly happen again.” This makes Anthropic the fastest-growing software company in history at its scale.

On scaling laws, Amodei directly contradicts the “diminishing returns” narrative: “From what we’ve seen at Anthropic… we don’t see any diminishing returns.” He cites SweetBench going from 3% to 72-80% in 18 months, and notes that the majority of code at Anthropic is now written with Claude’s involvement. The exponential continues.

The response to Jensen Huang’s criticism is explosive. When asked about Huang’s claim that Amodei “thinks he’s the only one who can build this safely and therefore wants to control the entire industry,” Amodei fires back: “I’ve never said anything like that. That’s an outrageous lie. That’s the most outrageous lie I’ve ever heard.”

But the most revealing moment is about the “doomer” label. Amodei’s anger is visceral: “I get very angry when people call me a doomer. My father died because of cures that could have happened a few years later. I understand the benefit of this technology.” This personal tragedy - losing his father to an illness that better technology might have treated - drives both his urgency and his frustration at being mischaracterized.

His business philosophy is clear: bet on enterprise/business use cases, not consumer chatbots. Why? “If I improve the model from undergrad to graduate level in biochemistry, maybe 1% of consumers care. But if I go to Pfizer, this is going to be the biggest deal in the world. They might pay 10x more.”

On Mark Zuckerberg’s talent raids: “What they are doing is trying to buy something that cannot be bought - alignment with the mission.” He claims Anthropic has lost very few people despite aggressive offers, and refused to compromise compensation principles to match them.

5 Insights From Amodei on Scaling and Business Strategy

• Anthropic’s revenue: $0 → $100M (2023) → $1B (2024) → $4.5B (H1 2025) - 10x annual growth, fastest software company in history at scale
• “We don’t see any diminishing returns” in scaling - directly contradicts industry pessimism about scaling laws
• Talent density over capital: “Would you rather do anything 10x cheaper or start with a large pile of money?”
• Enterprise focus over consumer: improvements that don’t matter to chatbot users can be “the biggest deal in the world” for Pfizer
• 20-25% chance models stop improving in next 2 years - but if they don’t, “people are getting fooled by the exponential”